CPALMSI 0019: Cytopathology | Dr Harman Sekhon | 13/10/2022 | 6:00 PM |

(1:14:26)

CPALMSI 0001: Overview Pathology Laboratory Medicine | Dr Catherine Morris | 13/08/2020 | 5:00 PM |

(1:18:43)

CPALMSI 0020: Clinical Forensic Medicine | Dr Rhonda Hutson | 10/11/2022 | 6:00 PM |

(1:28:18)

CPALMSI 0018: Forensic Pathology INTERACTIVE CASES | Dr Alfredo Walker | 06/09/2022 | 6:00 PM |

(2:34)

An analysis of the impact of ASXL1 mutations in patients with CP-CML treated in the SUSTRENIM trial

(3:54)

Paramedian Sagittal Approach to Paravertebral Block

(7:3)

Outcomes \u0026 predictors of survival in patients with R/R DLBCL: a population-based analysis

(2:16)

What is PET-PEESE in Meta Analysis? How to Detect Publication Bias? Practical Example with JASP

(8:26)

The evolving role of HSCT and optimal sequencing strategies for the treatment of R/R DLBCL

(1:49)

MLOps Monitoring and Feedback Loops

(17:17)

Results of a Phase I study of SEA-CD70, a CD70-directed antibody, combined with azacitidine for MDS

(2:15)

Lake Management: A Case Study

(2:23)